Lyell Immunopharma (LYEL) Return on Sales Growth (1y) (2021 - 2026)
Lyell Immunopharma (LYEL) Return on Sales Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | - |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 0.00 |
| 10 | Lyell Immunopharma | 281.33 Mn | 281.33 Mn | - | -33,196.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,196.00 |
| Dec 31, 2025 | 26,890.00 |
| Sep 30, 2025 | -3,152.00 |
| Jun 30, 2025 | -4,473.00 |
| Mar 31, 2025 | 6,558.00 |
| Dec 31, 2024 | -27,402.00 |
| Sep 30, 2024 | -857.00 |
| Jun 30, 2024 | -6,597.00 |
| Mar 31, 2024 | -23,688.00 |
| Dec 31, 2023 | -23,599.00 |
| Sep 30, 2023 | 59,991.00 |
| Jun 30, 2023 | -3,360.00 |
| Mar 31, 2023 | -965.00 |
| Dec 31, 2022 | 59.00 |
| Sep 30, 2022 | -62,771.00 |
| Jun 30, 2022 | 63.00 |
| Mar 31, 2022 | -294.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 13.00 |
| Jun 30, 2021 | -33.00 |